Close X
Monday, November 11, 2024
ADVT 
Health

'Ebola vaccine showing promising results'

Darpan News Desk IANS, 02 Dec, 2014 12:49 PM
    Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West African countries affected by the epidemic, a scientist from Oxford University said Monday.
     
    Speaking at a conference of African Immunologists in Nairobi, Adrian Hill, director of Oxford University's Jenner Institute, said the two vaccines will re-energise the fight against Ebola, Xinhua reported.
     
    "The two vaccines have demonstrated remarkable efficacy and have no side effects to Ebola patients. We anticipate their deployment will commence in January," Hill told African medical researchers.
     
    The World Health Organisation (WHO) Nov 29 revealed that 6,928 people have died of Ebola in Liberia, Guinea and Sierra Leone.
     
    At the same time, 16,000 people are infected with the Ebola virus and could succumb to death in the absence of proper treatment and care.
     
    Pharmaceutical giants, rich governments, foundations and multilateral agencies have contributed funds to support development of an Ebola vaccine.
     
    Hill said that clinical trials on Ebola vaccine have accelerated thanks to adequate funding and political attention.
     
    "Development of an Ebola vaccine is accelerating faster than anticipated. The vaccine is being tested in Mali where 80 people have received the jab," Hill said, adding that over 200 people have been vaccinated against Ebola globally.
     
    The clinical trials on Ebola vaccine commenced in September and the WHO will approve it once it passes efficacy and safety test.
     
    Hill revealed that pharmaceutical giants, British and American governments have collaborated to develop the Ebola vaccine.
     
    Clinical trials on Ebola vaccine have involved primates since the disease was discovered in 1976 in the Democratic Republic of Congo.
     
    "There was a breakthrough in the clinical trials targeting monkeys and the next phase will focus on the vaccines` efficacy on humans," Hill told scientists.
     
    He emphasised the vaccine will be a game changer in the war against Ebola in West and Central Africa.
     
    "The vaccine will be availed to high risk groups like health workers and people involved in burials," Hill said. 

    MORE Health ARTICLES

    Second-hand Smoke Leads To Obesity

    Second-hand Smoke Leads To Obesity
    Debunking a long-held popular belief that smoking cigarettes helps keep one slim, researchers have now found that even second hand exposure to cigarette smoke can cause weight gain.

    Second-hand Smoke Leads To Obesity

    Copper could help prevent Ebola spread

    Copper could help prevent Ebola spread
    Replacing frequently-touched surfaces, such as door handles, taps and light switches, with solid copper or copper alloy equivalents could be an...

    Copper could help prevent Ebola spread

    Inhaled Ebola vaccine could offer long-term protection

    Inhaled Ebola vaccine could offer long-term protection
    A single dose of a breathable, respiratory vaccine could provide long-term protection against the deadly Ebola virus, new research shows....

    Inhaled Ebola vaccine could offer long-term protection

    Sugar-rich fat maintains supply of brain stem cells

    Sugar-rich fat maintains supply of brain stem cells
    Fat and sugar are considered to be the culprits when it comes to obesity and related health complications but if researchers are to be believed...

    Sugar-rich fat maintains supply of brain stem cells

    Defective nerve insulation triggers migraine

    Defective nerve insulation triggers migraine
    The unbearable headache that migraine patients suffer is due to cellular-level changes in nerve structure, says a study....

    Defective nerve insulation triggers migraine

    Mild BP control adequate for people above 60

    Mild BP control adequate for people above 60
    Even a mild dose of drugs used to treat high blood pressure would be adequate for the elderly population who suffer from the condition, a study says....

    Mild BP control adequate for people above 60